NCT06271330View on ClinicalTrials.gov

Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

September 30, 2026

Conditions
Age-related Macular Degeneration
Interventions
DRUG

Faricimab

switch from previous anti-VEGF agents to faricimab

Trial Locations (1)

44000

RECRUITING

Ducloyer, Nantes

All Listed Sponsors
collaborator

Rennes University Hospital

OTHER

lead

Nantes University Hospital

OTHER